1. Home
  2. MDGL vs ROKU Comparison

MDGL vs ROKU Comparison

Compare MDGL & ROKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$520.16

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Logo Roku Inc.

ROKU

Roku Inc.

HOLD

Current Price

$102.64

Market Cap

14.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
ROKU
Founded
2011
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
14.4B
IPO Year
2005
2017

Fundamental Metrics

Financial Performance
Metric
MDGL
ROKU
Price
$520.16
$102.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
23
Target Price
$674.45
$123.26
AVG Volume (30 Days)
349.8K
2.3M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
41.32
166.29
EPS
N/A
0.59
Revenue
$180,133,000.00
$4,737,251,000.00
Revenue This Year
$58.39
$18.55
Revenue Next Year
$47.10
$12.14
P/E Ratio
N/A
$169.61
Revenue Growth
N/A
15.18
52 Week Low
$265.00
$57.01
52 Week High
$615.00
$116.66

Technical Indicators

Market Signals
Indicator
MDGL
ROKU
Relative Strength Index (RSI) 62.15 61.20
Support Level $411.87 $91.83
Resistance Level $610.00 $107.49
Average True Range (ATR) 26.99 4.71
MACD 3.75 1.02
Stochastic Oscillator 64.35 85.17

Price Performance

Historical Comparison
MDGL
ROKU

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

About ROKU Roku Inc.

Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 145 billion streaming hours in 2025. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.

Share on Social Networks: